Protective effect of sulglycotide on human gastric mucosa exposed to taurocholic acid. 1987

R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara

Sulglycotide is a non-systemic drug used in the treatment of peptic ulcer. It seems also to possess cytoprotective action. A double-blind cross-over study on the influence of oral sulglycotide on gastric mucosal cell loss induced by taurocholic acid (20 mM + HCl 7mM in 100 ml normal saline) was carried out in sixteen healthy volunteers by means of the DNA-loss technique. Each subject received either sulglycotide (400 mg thrice daily) or a placebo in random order on the basis of a double-blind cross-over design. Sulglycotide appeared to reduce the gastric cell loss induced by taurocholic acid. These results can explain the therapeutic effect of sulglycotide in peptic disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D012795 Sialoglycoproteins Glycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities. Polysialoglycoprotein,Sialoglycopeptide,Sialoglycopeptides,Sialoglycoprotein,Sialoprotein,Sialoproteins,Polysialoglycoproteins

Related Publications

R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
February 1999, Gut,
R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
August 1977, Fortschritte der Medizin,
R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
January 1983, International journal of tissue reactions,
R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
June 1988, The Journal of surgical research,
R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
August 1986, Pharmacological research communications,
R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
January 1985, Arzneimittel-Forschung,
R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
January 1978, Khirurgiia,
R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
October 1999, Doklady Akademii nauk,
R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
January 1985, Drugs under experimental and clinical research,
R Corinaldesi, and J Zurita, and A Cenedese, and V Stanghellini, and G Cavalli, and G Paparo, and L Barbara
December 1992, Pharmacological research,
Copied contents to your clipboard!